Gut bacterial molecule N-MNA rapidly repairs intestinal damage
Researchers at Rutgers Health have discovered a bacterial molecule, N-MNA, that rapidly repairs intestinal damage, potentially treating inflammatory bowel disease and other chronic gut disorders by boosting NAD, a coenzyme linked to aging. In tests on mice, flies, and human cells, N-MNA activated NAD, stimulating stem cell regeneration to heal damaged guts. Mice with inflamed colons recovered after injection, and fruit flies' seven-day survival rose from 43% to 78%. Human IBD patients with low N-MNA showed higher inflammation. N-MNA is produced by some gut bacteria, including probiotic strains, but not by humans. The team received a $3.6 million NIH grant to study it further, and Rutgers has filed a patent application.